Literature DB >> 34029667

Potential use of the Diels-Alder reaction in biomedical and nanomedicine applications.

Adeolu Oluwasanmi1, Clare Hoskins2.   

Abstract

The Diels-Alder reaction and its retro breakdown has garnered increasing research focus due to several of its advantageous properties including, atomic conservation, reversibility, and substituent retention. This is especially true in biomedical application and nanomedicine development which display a preference for rapid, efficient, and clean "click" chemistry reactions allowing for delivery of active ingredients and subsequent release upon temperature elevation. There are multiple variations on the Diels-Alder reaction based around substitution position and materials being coupled which can affect the temperature threshold for and rate of the retro reaction reversal. Hence, the Diels-Alder reaction offers a simple coupling reaction for active ingredients with tailorable release. In this review the incorporation of the Diels-Alder chemistries and linkers within the biomedical and nanomedicine field will be discussed, as well as its use in future potential technologies.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Diels-Alder; Drug delivery; Drug release; Intelligent delivery; Triggered release

Year:  2021        PMID: 34029667     DOI: 10.1016/j.ijpharm.2021.120727

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  2 in total

Review 1.  Sustainable Solvent-Free Diels-Alder Approaches in the Development of Constructive Heterocycles and Functionalized Materials: A Review.

Authors:  Aluru Rammohan; Alexey P Krinochkin; Albert F Khasanov; Dmitry S Kopchuk; Grigory V Zyryanov
Journal:  Top Curr Chem (Cham)       Date:  2022-08-11

2.  Hyaluronic Acid-PEG-Based Diels-Alder In Situ Forming Hydrogels for Sustained Intraocular Delivery of Bevacizumab.

Authors:  Blessing C Ilochonwu; Marko Mihajlovic; Roel F Maas-Bakker; Charis Rousou; Miao Tang; Mei Chen; Wim E Hennink; Tina Vermonden
Journal:  Biomacromolecules       Date:  2022-06-23       Impact factor: 6.978

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.